Sarah J. Schlesinger

Alter : 61

Vermögen : 1 504 880 USD

Größte Unternehmen :

Innoviva, Inc. -

Armata Pharmaceuticals, Inc.

Übersicht

Presently, Sarah J. Schlesinger occupies the position of Chairman of Rockefeller University Institutional Review Board.

She is also Director-Education & Training, Associate Professor at The Rockefeller University, Member of American Association for the Advancement of Science, Member of College of American Pathologists, Member of United States & Canadian Academy of Pathology and Director-Education & Training at Rockefeller University Center For Clinical & Translational and on the board of 7 other companies.

Dr. Schlesinger previously was Member-Infectious & Parasitic Disease Pathology at Armed Forces Institute of Pathology.

Dr. Schlesinger received an undergraduate degree from Wellesley College and a doctorate from Rush Medical College.

Aktuelle Stellungen und Verantwortungsbereiche Sarah J. Schlesinger

Name	Titel	Seit
Innoviva, Inc. (Pharmazeutika)	Independent Director	2018
Armata Pharmaceuticals, Inc. (Biotechnologie)	Independent Director	2020
AIDS Vaccine Advocacy Coalition	Director	-
Metabiota, Inc.	Director	-
The Hastings Center	Director	-
eGenesis, Inc.	Director	-
Global Viral	Director	-
Rockefeller University Institutional Review Board	Chairman	2017
The Rockefeller University	Director-Education & Training, Associate Professor	2003
American Association for the Advancement of Science	Member	-
College of American Pathologists	Member	-
United States & Canadian Academy of Pathology	Member	-
Rockefeller University Center For Clinical & Translational	Director-Education & Training	-

Anteile an Sarah J. Schlesinger

Name	Aktien	%	Wert
Innoviva, Inc. (INVA) (Pharmazeutika)	88 211	0,13%	1 504 880 USD
Armata Pharmaceuticals, Inc. (ARMP) (Biotechnologie)	0	0,0000%	0 USD

Sarah J. Schlesinger: Persönliches Netzwerk

Name	Verbundene Unternehmen
Jules Haimovitz	Innoviva, Inc. Armata Pharmaceuticals, Inc.
Odysseas Demosthenes Kostas	Innoviva, Inc. Armata Pharmaceuticals, Inc.
Steven Robert Martin	Armata Pharmaceuticals, Inc.
Mark A. Dipaolo	Innoviva, Inc.
Todd C. Peterson	Armata Pharmaceuticals, Inc.
Robin C. Kramer	Armata Pharmaceuticals, Inc.
Marianne Zhen	Innoviva, Inc.
Brian C. Varnum	Armata Pharmaceuticals, Inc.
Duane A. Morris	Armata Pharmaceuticals, Inc.
Todd R. Patrick	Armata Pharmaceuticals, Inc.